<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>) is a <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">heritable disorder</z:e> of connective tissue, affecting principally skeletal, ocular, and cardiovascular systems </plain></SENT>
<SENT sid="1" pm="."><plain>The most life-threatening manifestations are <z:hpo ids='HP_0004942'>aortic aneurysm</z:hpo> and dissection </plain></SENT>
<SENT sid="2" pm="."><plain>We investigated changes in the proteome of aortic media in patients with and without <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> to gain insight into molecular mechanisms leading to <z:hpo ids='HP_0001724'>aortic dilatation</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS AND RESULTS: Aortic samples were collected from 46 patients </plain></SENT>
<SENT sid="4" pm="."><plain>Twenty-two patients suffered from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>, 9 patients had <z:hpo ids='HP_0001647'>bicuspid aortic valve</z:hpo>, and 15 patients without <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue disorder</z:e> served as controls </plain></SENT>
<SENT sid="5" pm="."><plain>Aortic media was isolated and its proteome was analyzed in 12 patients with the use of 2-dimensional difference gel electrophoresis and mass spectrometry </plain></SENT>
<SENT sid="6" pm="."><plain>We found higher amounts of filamin A C-terminal fragment, calponin 1, vinculin, microfibril-associated <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> 4, and myosin-10 heavy chain in aortic media of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> <z:hpo ids='HP_0002617'>aneurysm</z:hpo> samples than in controls </plain></SENT>
<SENT sid="7" pm="."><plain>Regulation of filamin A C-terminal fragmentation was validated in <z:hpo ids='HP_0000001'>all</z:hpo> patient samples by immunoblotting </plain></SENT>
<SENT sid="8" pm="."><plain>Cleavage of filamin A and the calpain substrate spectrin was increased in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> and <z:hpo ids='HP_0001647'>bicuspid aortic valve</z:hpo> groups </plain></SENT>
<SENT sid="9" pm="."><plain>Extent of cleavage correlated positively with calpain 2 expression and negatively with the expression of its endogenous inhibitor calpastatin </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Our observation demonstrates for the first time upregulation of the C-terminal fragment of filamin A in dilated aortic media of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> and <z:hpo ids='HP_0001647'>bicuspid aortic valve</z:hpo> patients </plain></SENT>
<SENT sid="11" pm="."><plain>In addition, our results present evidence that the cleavage of filamin A is highly likely the result of the protease calpain </plain></SENT>
<SENT sid="12" pm="."><plain>Increased calpain activity might explain, at least in part, histological alterations in dilated aorta </plain></SENT>
</text></document>